glucagon has been researched along with tacrolimus in 6 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 17,757 | 2,319 | 6,661 |
Protein | Taxonomy | glucagon (IC50) | tacrolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 7.18 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Alejandro, R; Mintz, DH; Ricordi, C; Strasser, S; Todo, S | 1 |
Bechstein, WO; Dette, K; Gräf, KJ; Leder, K; Mueller, AR; Neuhaus, P; Schleicher, J; Schulz, E; Steinmüller, TM | 1 |
Blume, R; Knepel, W; Lux, G; Oetjen, E; Schwaninger, M | 1 |
Bhatt, HS; Easom, RA; Lawrence, MC | 1 |
Mueller, R; Naji, A; Rickels, MR; Teff, KL | 1 |
Han, DJ; Jung, CH; Jung, JH; Kim, DH; Kim, YH; Ko, Y; Kwon, H; Lim, SJ; Mun, S; Shin, S | 1 |
1 trial(s) available for glucagon and tacrolimus
Article | Year |
---|---|
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cholesterol; Cyclosporine; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Lipids; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus; Triglycerides | 1994 |
5 other study(ies) available for glucagon and tacrolimus
Article | Year |
---|---|
The effect of FK 506 on canine pancreatic islet cell function in beagle dogs.
Topics: Animals; Anti-Bacterial Agents; Blood Glucose; Dogs; Glucagon; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Tacrolimus | 1991 |
Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization.
Topics: Activating Transcription Factor 2; Animals; Calcineurin; Calcium; Calmodulin-Binding Proteins; Cell Line; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Gene Expression; Glucagon; Islets of Langerhans; Membrane Potentials; Phosphoprotein Phosphatases; Polyenes; Rats; Regulatory Sequences, Nucleic Acid; Sirolimus; Tacrolimus; Transcription Factors | 1993 |
NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cell Line; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA-Binding Proteins; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Islets of Langerhans; Isoquinolines; NFATC Transcription Factors; Nuclear Proteins; Peptide Fragments; Promoter Regions, Genetic; Protein Precursors; Rats; Sulfonamides; Tacrolimus; Transcription Factors; Transcription, Genetic | 2002 |
{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants.
Topics: Adult; Analysis of Variance; Arginine; Blood Glucose; Female; Glucagon; Humans; Immunosuppressive Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Tacrolimus | 2010 |
Lack of Improvement in Insulin Sensitivity After Pancreas Transplantation in Recipients With a High Level of Calcineurin Inhibitors.
Topics: Adult; Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Kaplan-Meier Estimate; Male; Middle Aged; Pancreas Transplantation; Tacrolimus | 2021 |